MCM
IRWD icon

Mazama Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mazama Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,990
Closed -$29K – 273
2013
Q4 		$29K Buy
2,990
+1,789
+149% +$16.1K 0.01% 203
2013
Q3 		$12K Buy
+1,201
New +$11.8K 0.01% 240

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mazama Capital Management's IRWD Position: Q1 2014 in Review

Mazama Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2014, closing a stake of 2,990 shares — an estimated $29K sold.

Mazama Capital Management first reported a position in IRWD in Q3 2013 and held it in 2 quarters. The position peaked at $29K in Q4 2013. 138 funds tracked by Wall St. Rank hold IRWD as of Q1 2014.

  • Mazama Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Mazama Capital Management sold 2,990 Ironwood Pharmaceuticals shares in Q1 2014, an estimated $29K.
  • Mazama Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • Mazama Capital Management's Ironwood Pharmaceuticals position peaked at $29K in Q4 2013.
  • 138 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2014.

Based on Mazama Capital Management's 13F filing for Q1 2014, filed 3 Apr 2014.